Literature DB >> 7635113

Issues associated with the design of a national probability sample for human exposure assessment.

T M Ezzati-Rice1, R S Murphy.   

Abstract

Data obtained from national probability sample surveys provide important information on the prevalence of various health conditions and distributions of physical and biochemical characteristics of the U.S. population. The sample design of a survey specifies how sampling from a designated population over a stated period is to be accomplished. A survey's analytical objectives and interests--in particular subpopulations--affect the sample design strategy. Selected subdomains of the population often must be oversampled so that estimates can be made with acceptable precision. This article addresses sample design considerations for a national probability sample for human tissue monitoring and specimen banking. Among the sampling issues addressed are the oversampling of special populations e.g., minority groups and at-risk groups such as low income or elderly persons; geographic coverage; and sample size considerations. The sample design for a major health survey, the Third National Health and Nutrition Examination Survey (NHANES III), is used to illustrate a complex, multistage probability sample design and to highlight some of the sampling issues discussed in this article.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635113      PMCID: PMC1519024          DOI: 10.1289/ehp.95103s355

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  2 in total

1.  Comparison of FRAX Scores of Southern California Females of Mexican Descent Using US Hispanic and Mexico Database.

Authors:  Keaton M Nasser; Augusto Focil; Stuart L Silverman
Journal:  J Osteoporos       Date:  2011-05-25

2.  Building a Population Representative Pediatric Biobank: Lessons Learned From the Greater Cincinnati Childhood Cohort.

Authors:  Lisa J Martin; Liza Bronner Murrison; Melinda Butsch Kovacic
Journal:  Front Public Health       Date:  2021-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.